322 related articles for article (PubMed ID: 33509657)
21. Indirubin attenuates IL-17A-induced CCL20 expression and production in keratinocytes through repressing TAK1 signaling pathway.
Zhao J; Xie X; Di T; Liu Y; Qi C; Chen Z; Li P; Wang Y
Int Immunopharmacol; 2021 May; 94():107229. PubMed ID: 33611057
[TBL] [Abstract][Full Text] [Related]
22. Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis.
Harper EG; Guo C; Rizzo H; Lillis JV; Kurtz SE; Skorcheva I; Purdy D; Fitch E; Iordanov M; Blauvelt A
J Invest Dermatol; 2009 Sep; 129(9):2175-83. PubMed ID: 19295614
[TBL] [Abstract][Full Text] [Related]
23. Early-onset pediatric atopic dermatitis is T
Esaki H; Brunner PM; Renert-Yuval Y; Czarnowicki T; Huynh T; Tran G; Lyon S; Rodriguez G; Immaneni S; Johnson DB; Bauer B; Fuentes-Duculan J; Zheng X; Peng X; Estrada YD; Xu H; de Guzman Strong C; Suárez-Fariñas M; Krueger JG; Paller AS; Guttman-Yassky E
J Allergy Clin Immunol; 2016 Dec; 138(6):1639-1651. PubMed ID: 27671162
[TBL] [Abstract][Full Text] [Related]
24. Regulation of the psoriatic chemokine CCL20 by E3 ligases Trim32 and Piasy in keratinocytes.
Liu Y; Lagowski JP; Gao S; Raymond JH; White CR; Kulesz-Martin MF
J Invest Dermatol; 2010 May; 130(5):1384-90. PubMed ID: 20054338
[TBL] [Abstract][Full Text] [Related]
25. Transcriptome profiling unveils the role of cholesterol in IL-17A signaling in psoriasis.
Varshney P; Narasimhan A; Mittal S; Malik G; Sardana K; Saini N
Sci Rep; 2016 Jan; 6():19295. PubMed ID: 26781963
[TBL] [Abstract][Full Text] [Related]
26. Development of psoriasis by continuous neutrophil infiltration into the epidermis.
Katayama H
Exp Dermatol; 2018 Oct; 27(10):1084-1091. PubMed ID: 30019426
[TBL] [Abstract][Full Text] [Related]
27. IL-4 Modulates CCL11 and CCL20 Productions from IL-1β-Stimulated Human Periodontal Ligament Cells.
Hosokawa Y; Hosokawa I; Shindo S; Ozaki K; Matsuo T
Cell Physiol Biochem; 2016; 38(1):153-9. PubMed ID: 26765337
[TBL] [Abstract][Full Text] [Related]
28. Psoriasis and other Th17-mediated skin diseases.
Tokura Y; Mori T; Hino R
J UOEH; 2010 Dec; 32(4):317-28. PubMed ID: 21226422
[TBL] [Abstract][Full Text] [Related]
29. Expression of IL-33 in the epidermis: The mechanism of induction by IL-17.
Meephansan J; Komine M; Tsuda H; Karakawa M; Tominaga S; Ohtsuki M
J Dermatol Sci; 2013 Aug; 71(2):107-14. PubMed ID: 23764374
[TBL] [Abstract][Full Text] [Related]
30. Catechins inhibit CCL20 production in IL-17A-stimulated human gingival fibroblasts.
Hosokawa Y; Hosokawa I; Ozaki K; Nakanishi T; Nakae H; Matsuo T
Cell Physiol Biochem; 2009; 24(5-6):391-6. PubMed ID: 19910679
[TBL] [Abstract][Full Text] [Related]
31. Chrysin alleviates imiquimod-induced psoriasis-like skin inflammation and reduces the release of CCL20 and antimicrobial peptides.
Li HJ; Wu NL; Pu CM; Hsiao CY; Chang DC; Hung CF
Sci Rep; 2020 Feb; 10(1):2932. PubMed ID: 32076123
[TBL] [Abstract][Full Text] [Related]
32. IL-9 induces IL-8 production via STIM1 activation and ERK phosphorylation in epidermal keratinocytes: A plausible mechanism of IL-9R in atopic dermatitis.
Hong CH; Chang KL; Wang HJ; Yu HS; Lee CH
J Dermatol Sci; 2015 Jun; 78(3):206-14. PubMed ID: 25840641
[TBL] [Abstract][Full Text] [Related]
33. Keratinocyte Expression of A20/TNFAIP3 Controls Skin Inflammation Associated with Atopic Dermatitis and Psoriasis.
Devos M; Mogilenko DA; Fleury S; Gilbert B; Becquart C; Quemener S; Dehondt H; Tougaard P; Staels B; Bachert C; Vandenabeele P; Van Loo G; Staumont-Salle D; Declercq W; Dombrowicz D
J Invest Dermatol; 2019 Jan; 139(1):135-145. PubMed ID: 30118730
[TBL] [Abstract][Full Text] [Related]
34. Suppressor of cytokine signaling 1/JAB and suppressor of cytokine signaling 3/cytokine-inducible SH2 containing protein 3 negatively regulate the signal transducers and activators of transcription signaling pathway in normal human epidermal keratinocytes.
Yamasaki K; Hanakawa Y; Tokumaru S; Shirakata Y; Sayama K; Hanada T; Yoshimura A; Hashimoto K
J Invest Dermatol; 2003 Apr; 120(4):571-80. PubMed ID: 12648219
[TBL] [Abstract][Full Text] [Related]
35. Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines.
Giustizieri ML; Mascia F; Frezzolini A; De Pità O; Chinni LM; Giannetti A; Girolomoni G; Pastore S
J Allergy Clin Immunol; 2001 May; 107(5):871-7. PubMed ID: 11344355
[TBL] [Abstract][Full Text] [Related]
36. IL-22, but not IL-17, dominant environment in cutaneous T-cell lymphoma.
Miyagaki T; Sugaya M; Suga H; Kamata M; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
Clin Cancer Res; 2011 Dec; 17(24):7529-38. PubMed ID: 22048239
[TBL] [Abstract][Full Text] [Related]
37. Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation.
Johnston A; Fritz Y; Dawes SM; Diaconu D; Al-Attar PM; Guzman AM; Chen CS; Fu W; Gudjonsson JE; McCormick TS; Ward NL
J Immunol; 2013 Mar; 190(5):2252-62. PubMed ID: 23359500
[TBL] [Abstract][Full Text] [Related]
38. IL-4 Downregulates IL-1β and IL-6 and Induces GATA3 in Psoriatic Epidermal Cells: Route of Action of a Th2 Cytokine.
Onderdijk AJ; Baerveldt EM; Kurek D; Kant M; Florencia EF; Debets R; Prens EP
J Immunol; 2015 Aug; 195(4):1744-52. PubMed ID: 26170379
[TBL] [Abstract][Full Text] [Related]
39. Human antimicrobial peptide LL-37 modulates proinflammatory responses induced by cytokine milieus and double-stranded RNA in human keratinocytes.
Chen X; Takai T; Xie Y; Niyonsaba F; Okumura K; Ogawa H
Biochem Biophys Res Commun; 2013 Apr; 433(4):532-7. PubMed ID: 23524263
[TBL] [Abstract][Full Text] [Related]
40. RIPK1 downregulation in keratinocyte enhances TRAIL signaling in psoriasis.
Saito N; Honma M; Shibuya T; Iinuma S; Igawa S; Kishibe M; Ishida-Yamamoto A
J Dermatol Sci; 2018 Jul; 91(1):79-86. PubMed ID: 29661487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
